leisure time -WSS

leisure time

author：hotspot 2025-09-28 01:36:00 - browse：7

Scientist pipetting in a biotech lab -- biotech coverage from STAT — A researcher working in the lab at Crinetics Pharmaceuticals in San Diego. Courtesy Crinetics

SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San Diego biotech a step closer to applying for Food and Drug Administration approval — and entry into a crowded market with blockbuster therapies sold by pharma giants.

In the Phase 3 study, dubbed PATHFNDR-1, nearly 60 patients were randomly assigned to receive a placebo or a daily dose of paltusotine, an oral medicine designed to lower levels of growth hormone, which is produced in excess by people with acromegaly. After 36 weeks of treatment, 25 of the 30 patients given the drug had growth-factor levels that were within the normal range compared to just 1 of 28 participants who took the placebo, a difference that was statistically significant. Researchers also found that the treatment’s side effects were mild overall.

Crinetics plans to file for FDA approval if it gets positive results from a second, ongoing Phase 3 trial of the drug in acromegaly patients. The biotech expects results from that study, known as PATHFNDR-2, by the first quarter of next year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： SEC charges former device maker CEO with $41 million fraud

WSS

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

In Spain, a hospital brews its own CAR

UPS workers' union leader explains what's at stake as strike edges closer

Violet CEO on training clinicians to promote more inclusive care

Carvykti CAR

North Korean leader's powerful sister says warplanes repelled US spy plane

leisure time

leisure time

hotspot

Guidelines to prevent youth baseball injuries need more muscle

House panel to mark up pandemic

Guidelines to prevent youth baseball injuries need more muscle

Carvykti CAR

Anesthesiologist group: stop taking Ozempic before surgery

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Neutralizing antibodies against HIV shows promise in children

After affirmative action ruling, medical educators look to 'holistic review'

US intelligence assessment says Iran not currently developing nuclear weapons

focus

Medicare drug price negotiation hasn't dried up venture capital

Medicare drug price negotiation hasn't dried up venture capital

UPS workers' union leader explains what's at stake as strike edges closer

US intelligence assessment says Iran not currently developing nuclear weapons

Medicare Advantage beneficiaries sue Humana over algorithm use

What STAT readers think about the FDA and patient advocacy

focus

focus

Wikipedia

hotspot